Issues
-
Cover Image
Cover Image
Timing of GLA in relation to vaccination impacts the pattern of OT1 cell accumulation. Representative bioluminescent images show site-specific accumulation of OT1 cells in different groups of mice 4 days post hind footpad vaccination. Vaccine-primed T cells accumulated in the draining lymph nodes in mice that received GVAX only or when GLA 24 was given 24 hrs post GVAX. However, when GLA is coadministered with GVAX, a systemic pattern of T-cell accumulation was observed. For details, see article by Kadayakkara and colleagues on page 51. - PDF Icon PDF LinkTable of Contents
Cancer Research
Table of Contents
Breaking Advances
From the Editor’s Chair
Reviews
Priority Report
The Cyclic AMP Pathway Is a Sex-Specific Modifier of Glioma Risk in Type I Neurofibromatosis Patients
Clinical Studies
Oncolytic Measles Virus Expressing the Sodium Iodide Symporter to Treat Drug-Resistant Ovarian Cancer
Integrated Systems and Technologies
Microenvironment and Immunology
Akt1 and Akt3 Exert Opposing Roles in the Regulation of Vascular Tumor Growth
Molecular and Cellular Pathobiology
PLK1 Phosphorylates PAX3-FOXO1, the Inhibition of Which Triggers Regression of Alveolar Rhabdomyosarcoma
Therapeutics, Targets, and Chemical Biology
VEGF-Targeted Therapy Stably Modulates the Glycolytic Phenotype of Tumor Cells
Foretinib Is Effective Therapy for Metastatic Sonic Hedgehog Medulloblastoma
Mdm2 and Aurora Kinase A Inhibitors Synergize to Block Melanoma Growth by Driving Apoptosis and Immune Clearance of Tumor Cells
Tumor and Stem Cell Biology
Contributions to Drug Resistance in Glioblastoma Derived from Malignant Cells in the Sub-Ependymal Zone
α-Tubulin Acetylation Elevated in Metastatic and Basal-like Breast Cancer Cells Promotes Microtentacle Formation, Adhesion, and Invasive Migration
B-Raf Inhibitors Induce Epithelial Differentiation in BRAF-Mutant Colorectal Cancer Cells
SYK Is a Candidate Kinase Target for the Treatment of Advanced Prostate Cancer
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio® (avelumab), a pharmaceutical owned by Merck. None of these funds are being, or will be, used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.